About Prism Medico And Pharmacy Limited
Data last updated: 14 July 2026
Prism Medico And Pharmacy Limited is a public limited company based in Kala Amb, Himachal Pradesh, India. It specialises in industrial chemicals, a part of the broader chemicals and materials sector. Incorporated on 22 March 2002, the company has been in operation for over 24 years.
Registered with ROC Himachal Pradesh under CIN L24100HP2002PLC009299. Listed on BSE: 512217.
Capital: an authorised share capital of ₹25 Cr and a paid-up capital of ₹13.56 Cr. It is led by directors including Davender Singh and Pardeep Kumar.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Suketi Road, Kala Amb, Himachal Pradesh, India – 173030.
As per BSE-filed standalone financials for FY 2026, the company reported a revenue of ₹2.44 Cr, reflecting significant growth compared to the previous year. The net worth stands at ₹15.41 Cr (up 2.11% YoY). Total assets are valued at ₹15.61 Cr (up 0.3% YoY).
The company is associated with 1 brand - Prism Medico.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website prismmedico.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered AddressSuketi Road, Kala Amb, Himachal Pradesh, India – 173030
-
IndustryChemicals and Materials, Industrial Chemicals
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Prism Medico And Pharmacy Limited
Prism Medico And Pharmacy Limited has 5 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24100HP2002PLC009299, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24100HP2002PLC009299 | Current |
| L51109HP2002PLC009299 | Previous |
| U51109WB2002PLC094419 | Previous |
| L51109MH2002PLC206595 | Previous |
| L51109WB2002PLC094419 | Previous |
| L51109PB2002PLC047444 | Previous |
Associated Brands with Prism Medico And Pharmacy Limited
Prism Medico And Pharmacy Limited operates one associated brand: Prism Medico. These brands represent Prism Medico And Pharmacy Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Drugs for multiple therapeutic areas are manufactured through R&D efforts. | prismmedico.in |
Competitors & Alternatives of Prism Medico And Pharmacy Limited
Brands and companies operating in the same space as Prism Medico And Pharmacy Limited include Merck, Roivant Sciences, AbbVie and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Merck
|
Pharmaceutical products are manufactured and marketed worldwide. | Kenilworth, United Kingdom, United Kingdom | 1891 |
Roivant Sciences
|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | New York, United States, United States | 2014 |
AbbVie
|
Biopharmaceutical research and drug development are conducted globally by AbbVie. | Chicago, United States, United States | 2012 |
Lilly
|
Traditional pharmaceutical medicines are developed for multiple health fields. | United States | 1876 |
Gilead
|
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | Foster City, United States, United States | 1987 |
United Therapeutics
|
Treatments for chronic and life-threatening diseases are developed and commercialized. | Silver Spring, United States, United States | 1998 |
Roche
|
Pharmaceuticals and diagnostics kits are developed for various diseases. | Basel, Switzerland, Switzerland | 1896 |
Ascendis Pharma
|
Long-acting prodrug therapies are developed for endocrine and rare diseases. | Hellerup, Denmark, Denmark | 2007 |
MorphoSys
|
Therapeutic antibodies for cancer and other diseases are developed. | Planegg, Germany, Germany | 1992 |
Vertex Pharmaceuticals
|
Developer of drugs for the treatment of multiple disorders | United States | 1989 |
Business Activity of Prism Medico And Pharmacy Limited
Prism Medico And Pharmacy Limited operates primarily in the trade sector. The company has 1 registered business activity segment, reflecting its diverse operational portfolio.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Locked | Trade | Locked | Wholesale Trading | Locked |
Detailed business activity records for Prism Medico And Pharmacy Limited
Activity codes and turnover contribution percentages require an active report plan.
- Activity group codes
- Detailed activity codes
- Turnover contribution
Verified entity values are shown only after access is granted.
Auditor Details of Prism Medico And Pharmacy Limited
Prism Medico And Pharmacy Limited is audited by GARG MENDIRATTA & ASSOCIATES (ICAI peer reviewed, certificate valid till 2027-12-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| GARG MENDIRATTA & ASSOCIATES (ICAI peer reviewed, certificate valid till 2027-12-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Prism Medico And Pharmacy Limited
Prism Medico And Pharmacy Limited is currently managed by 4 directors, with 13 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Davender Singh
Also directs:
Prism Medico And Pharmacy Limited
|
Director | 31 Jan 2022 | 4 Years 6 Months | Current |
|
Pardeep Kumar
Also directs:
Prism Medico And Pharmacy Limited
|
Director | 31 Jan 2022 | 4 Years 6 Months | Current |
| Dinesh Kumar | Director | 14 Aug 2023 | 3 Years 0 Months | Current |
|
Sakshi Laller
Also directs:
Prism Medico And Pharmacy Limited, Symbiosis Biolife Llp, Infuze Well Private Limited and 1 more
|
Whole-Time Director | 16 May 2023 | 3 Years 3 Months | Current |
Financials of Prism Medico And Pharmacy Limited FY 2026 filings available
Prism Medico And Pharmacy Limited reported revenue of ₹2.44 Cr (up 286.68% YoY) for FY 2026.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹2.44 Cr | ₹63.19 Lakh | ₹2.93 Cr | ₹1.27 Cr | ₹8.44 Cr | ₹16.76 Cr | ₹26.89 Cr | ₹36.31 Cr |
| Other Income | ₹2.61 Lakh | ₹1.65 Lakh | ₹12.22 Lakh | ₹17,000 | ₹0 | ₹0 | ₹0 | ₹21.87 Lakh |
| Total Income | ₹2.47 Cr | ₹64.84 Lakh | ₹3.05 Cr | ₹1.27 Cr | ₹8.44 Cr | ₹16.76 Cr | ₹26.89 Cr | ₹36.52 Cr |
| Cost of Materials Consumed | ₹1.57 Cr | ₹44.85 Lakh | ₹2.56 Cr | ₹1.14 Cr | ₹10.55 Cr | ₹21.47 Cr | ₹25.7 Cr | ₹0 |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹35.28 Cr |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | -₹1.92 Cr | -₹4.8 Cr | ₹91.38 Lakh | -₹7.61 Lakh |
| Employee Benefit Expense | ₹6.03 Lakh | ₹4.26 Lakh | ₹3.4 Lakh | ₹4.66 Lakh | ₹19.04 Lakh | ₹16.76 Lakh | ₹21.9 Lakh | ₹24.63 Lakh |
| Finance Costs | ₹33,000 | ₹17,000 | ₹71,000 | ₹3,000 | ₹4,000 | ₹2,000 | ₹2,000 | ₹2,000 |
| Depreciation & Amortisation | ₹35,000 | ₹42,000 | ₹52,000 | ₹66,000 | ₹86,000 | ₹1.23 Lakh | ₹1.76 Lakh | ₹2.67 Lakh |
| Other Expenses | ₹40.4 Lakh | ₹21.72 Lakh | ₹46.82 Lakh | ₹18.03 Lakh | ₹11.55 Lakh | ₹9.04 Lakh | ₹11.05 Lakh | ₹75.27 Lakh |
| Total Expenses | ₹2.04 Cr | ₹71.42 Lakh | ₹3.08 Cr | ₹1.37 Cr | ₹8.94 Cr | ₹16.94 Cr | ₹26.96 Cr | ₹36.23 Cr |
| Profit Before Exceptional Items & Tax | ₹42.96 Lakh | -₹6.58 Lakh | -₹2.79 Lakh | -₹10.22 Lakh | -₹49.9 Lakh | -₹17.51 Lakh | -₹6.8 Lakh | ₹29.34 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹42.96 Lakh | -₹6.58 Lakh | -₹2.79 Lakh | -₹10.22 Lakh | -₹49.9 Lakh | -₹17.51 Lakh | -₹6.8 Lakh | ₹29.34 Lakh |
| Total Tax Expense | ₹11.12 Lakh | -₹1.71 Lakh | -₹66,000 | -₹2.59 Lakh | -₹13 Lakh | -₹4.51 Lakh | -₹1.78 Lakh | -₹68,000 |
| Net Profit | ₹31.84 Lakh | -₹4.87 Lakh | -₹2.13 Lakh | -₹7.64 Lakh | -₹36.9 Lakh | -₹13 Lakh | -₹5.02 Lakh | ₹36.96 Lakh |
| Other Comprehensive Income | ₹0 | ₹0 | ₹12,000 | ₹2.68 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹31.84 Lakh | -₹4.87 Lakh | -₹2.01 Lakh | ₹2.61 Cr | -₹36.9 Lakh | -₹13 Lakh | -₹5.02 Lakh | ₹36.96 Lakh |
| EBITDA (computed) | ₹43.64 Lakh | -₹5.99 Lakh | -₹1.56 Lakh | -₹9.53 Lakh | -₹49 Lakh | -₹16.26 Lakh | -₹5.02 Lakh | ₹32.03 Lakh |
| Basic EPS | ₹0.53 | ₹-0.08 | ₹0.00 | ₹-0.01 | ₹0.00 | ₹-0.02 | ₹-0.01 | ₹0.61 |
| Diluted EPS | ₹0.53 | ₹-0.08 | ₹0.00 | ₹-0.01 | ₹0.00 | ₹-0.02 | ₹-0.01 | ₹0.61 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹15.61 Cr | ₹15.56 Cr | ₹15.24 Cr | ₹15.39 Cr | ₹12.57 Cr | ₹21.54 Lakh Cr | ₹21.58 Lakh Cr | ₹16.97 Cr |
| Non-current Assets | ₹15.15 Lakh | ₹26.62 Lakh | ₹25.39 Lakh | ₹25.26 Lakh | ₹23.33 Lakh | ₹205,215 Cr | ₹201,935 Cr | ₹10.09 Cr |
| Current Assets | ₹15.46 Cr | ₹15.3 Cr | ₹14.99 Cr | ₹15.14 Cr | ₹12.34 Cr | ₹19.49 Lakh Cr | ₹19.56 Lakh Cr | ₹6.89 Cr |
| Property, Plant & Equipment | ₹2.58 Lakh | ₹2.93 Lakh | ₹3.36 Lakh | ₹3.88 Lakh | ₹4.54 Lakh | ₹5,534.09 Cr | ₹6,773.81 Cr | ₹8.54 Lakh |
| Inventories | ₹6.77 Cr | ₹6.77 Cr | ₹6.77 Cr | ₹6.77 Cr | ₹6.77 Cr | ₹484,662 Cr | ₹4,757.29 Cr | ₹96.16 Lakh |
| Trade Receivables | ₹3.93 Cr | ₹3.58 Cr | ₹3.69 Cr | ₹4.76 Cr | ₹4.88 Cr | ₹13.51 Lakh Cr | ₹18.34 Lakh Cr | ₹3.76 Cr |
| Cash & Equivalents | ₹6.37 Lakh | ₹6.54 Lakh | ₹8.36 Lakh | ₹9.58 Lakh | ₹5.51 Lakh | ₹8,413.29 Cr | ₹11,176 Cr | ₹11.76 Lakh |
| Equity (Net Worth) | ₹15.41 Cr | ₹15.09 Cr | ₹15.14 Cr | ₹15.16 Cr | ₹12.55 Cr | ₹12.93 Lakh Cr | ₹13.06 Lakh Cr | ₹13.15 Cr |
| Equity Share Capital | ₹6.06 Cr | ₹6.06 Cr | ₹6.06 Cr | ₹6.06 Cr | ₹6.06 Cr | ₹606,343 Cr | ₹606,343 Cr | ₹6.06 Cr |
| Borrowings (Non-current) | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Borrowings (Current) | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Debt (computed) | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Current Liabilities | ₹19.99 Lakh | ₹47.17 Lakh | ₹7.07 Lakh | ₹23.17 Lakh | ₹1.74 Lakh | ₹861,612 Cr | ₹852,817 Cr | ₹3.82 Cr |
| Total Liabilities | ₹19.99 Lakh | ₹47.17 Lakh | ₹10.15 Lakh | ₹23.17 Lakh | ₹1.74 Lakh | ₹861,612 Cr | ₹852,817 Cr | ₹3.82 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹17,000 | -₹1.65 Lakh | -₹50,000 | ₹2.95 Cr | -₹2.38 Cr |
| Investing Cash Flow | ₹0 | ₹0 | ₹0 | -₹2.91 Cr | ₹2.35 Cr |
| Financing Cash Flow | -₹34,000 | -₹17,000 | -₹71,000 | -₹3,000 | -₹4,600 |
| Capital Expenditure | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Free Cash Flow (computed) | ₹17,000 | -₹1.65 Lakh | -₹50,000 | ₹2.95 Cr | -₹2.38 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹17,000 | -₹1.82 Lakh | -₹1.21 Lakh | ₹4.07 Lakh | -₹2.9 Lakh |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹28.14 Lakh | ₹7.1 Lakh | ₹50.23 Lakh | ₹1.59 Cr | ₹7.28 Lakh | ₹20.86 Lakh | ₹28.78 Lakh | ₹6.27 Lakh |
| Other Income | ₹21,000 | ₹69,000 | ₹1.67 Lakh | ₹4,000 | ₹1.09 Lakh | ₹35,000 | ₹0 | ₹21,000 |
| Total Income | ₹28.35 Lakh | ₹7.79 Lakh | ₹51.9 Lakh | ₹1.59 Cr | ₹8.37 Lakh | ₹21.21 Lakh | ₹28.78 Lakh | ₹6.48 Lakh |
| Cost of Materials Consumed | ₹21.53 Lakh | ₹4.25 Lakh | ₹45.35 Lakh | ₹85.75 Lakh | ₹1.15 Lakh | ₹15.22 Lakh | ₹23.68 Lakh | ₹4.8 Lakh |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹2.69 Lakh | ₹1.19 Lakh | ₹1.2 Lakh | ₹95,000 | ₹1.1 Lakh | ₹1.13 Lakh | ₹1.03 Lakh | ₹1 Lakh |
| Finance Costs | ₹3,000 | ₹2,000 | ₹28,000 | ₹0 | ₹13,000 | ₹0 | ₹0 | ₹4,000 |
| Depreciation & Amortisation | ₹6,000 | ₹6,000 | ₹10,000 | ₹13,000 | ₹3,000 | ₹13,000 | ₹13,000 | ₹13,000 |
| Other Expenses | ₹16.34 Lakh | ₹3.61 Lakh | ₹13.45 Lakh | ₹7.01 Lakh | ₹3.7 Lakh | ₹5.63 Lakh | ₹2.94 Lakh | ₹9.45 Lakh |
| Total Expenses | ₹40.65 Lakh | ₹9.13 Lakh | ₹60.38 Lakh | ₹93.84 Lakh | ₹6.11 Lakh | ₹22.11 Lakh | ₹27.78 Lakh | ₹15.42 Lakh |
| Profit Before Exceptional Items & Tax | -₹12.3 Lakh | -₹1.34 Lakh | -₹8.48 Lakh | ₹65.07 Lakh | ₹2.26 Lakh | -₹90,000 | ₹1 Lakh | -₹8.94 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹12.3 Lakh | -₹1.34 Lakh | -₹8.48 Lakh | ₹65.07 Lakh | ₹2.26 Lakh | -₹90,000 | ₹1 Lakh | -₹8.94 Lakh |
| Total Tax Expense | ₹11.78 Lakh | ₹0 | ₹0 | -₹66,000 | -₹1.89 Lakh | ₹6,000 | ₹6,000 | ₹6,000 |
| Net Profit | -₹24.08 Lakh | -₹1.34 Lakh | -₹8.48 Lakh | ₹65.73 Lakh | ₹4.15 Lakh | -₹96,000 | ₹94,000 | -₹9 Lakh |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | -₹24.08 Lakh | -₹1.34 Lakh | -₹8.48 Lakh | ₹65.73 Lakh | ₹4.15 Lakh | -₹96,000 | ₹94,000 | -₹9 Lakh |
| EBITDA (computed) | -₹12.21 Lakh | -₹1.26 Lakh | -₹8.1 Lakh | ₹65.2 Lakh | ₹2.42 Lakh | -₹77,000 | ₹1.13 Lakh | -₹8.77 Lakh |
| Basic EPS | ₹-0.30 | ₹-0.02 | ₹0.00 | ₹0.01 | ₹0.07 | ₹0.00 | ₹0.00 | ₹0.00 |
| Diluted EPS | ₹-0.30 | ₹-0.02 | ₹0.00 | ₹0.01 | ₹0.07 | ₹0.00 | ₹0.00 | ₹0.00 |
| Metrics | FY 2019 |
|---|---|
| Revenue from Operations | ₹54.43 Cr |
| Other Income | ₹29.61 Lakh |
| Total Income | ₹54.72 Cr |
| Cost of Materials Consumed | ₹0 |
| Purchases of Stock-in-Trade | ₹53.13 Cr |
| Changes in Inventories | ₹10.29 Lakh |
| Employee Benefit Expense | ₹27.09 Lakh |
| Finance Costs | ₹10.73 Lakh |
| Depreciation & Amortisation | ₹38.27 Lakh |
| Other Expenses | ₹82.61 Lakh |
| Total Expenses | ₹54.82 Cr |
| Profit Before Exceptional Items & Tax | -₹9.66 Lakh |
| Exceptional Items | ₹0 |
| Profit Before Tax | -₹9.66 Lakh |
| Total Tax Expense | -₹6.74 Lakh |
| Net Profit | ₹4.02 Lakh |
| attributable to Owners | ₹0 |
| attributable to NCI | ₹0 |
| Other Comprehensive Income | ₹0 |
| Total Comprehensive Income | ₹4.02 Lakh |
| EBITDA (computed) | ₹39.34 Lakh |
| Basic EPS | ₹0.07 |
| Diluted EPS | ₹0.07 |
| Metrics | FY 2019 |
|---|---|
| Total Assets | ₹21.2 Cr |
| Non-current Assets | ₹10.37 Cr |
| Current Assets | ₹10.84 Cr |
| Property, Plant & Equipment | ₹8.91 Cr |
| Inventories | ₹1.39 Cr |
| Trade Receivables | ₹3.13 Cr |
| Cash & Equivalents | ₹40.69 Lakh |
| Equity (Net Worth) | ₹12.91 Cr |
| Equity Share Capital | ₹6.06 Cr |
| Borrowings (Non-current) | ₹0 |
| Borrowings (Current) | ₹2.27 Cr |
| Total Debt (computed) | ₹2.27 Cr |
| Current Liabilities | ₹8.27 Cr |
| Total Liabilities | ₹8.29 Cr |
| Metrics |
|---|
Shareholding Pattern of Prism Medico And Pharmacy Limited
As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 25.49%, retail and other public shareholders hold 74.51% of Prism Medico And Pharmacy Limited. The company had 4,295 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 25.49% | 25.00% | 25.00% | 25.00% | 25.00% | 25.00% |
| Public | 74.51% | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% |
| Mar 2026 | Mar 2025 | Mar 2024 | |
|---|---|---|---|
| Promoters | 25.49% | 25.00% | 25.00% |
| Public | 74.51% | 75.00% | 75.00% |
| Promoter change (YoY, %pts) | +0.49 | +0.00 | - |
Charges & Borrowings Prism Medico And Pharmacy Limited
Prism Medico And Pharmacy Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Prism Medico And Pharmacy Limited
View historical data on people associated with Prism Medico And Pharmacy Limited, including employment history and EPFO contributions.
Employee and EPFO history for Prism Medico And Pharmacy Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Prism Medico And Pharmacy Limited
GST registrations and filing compliance for Prism Medico And Pharmacy Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Prism Medico And Pharmacy Limited
Credit ratings, litigation, and regulatory alerts for Prism Medico And Pharmacy Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Prism Medico And Pharmacy Limited
MSME payment history for Prism Medico And Pharmacy Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Prism Medico And Pharmacy Limited
Corporate group structure for Prism Medico And Pharmacy Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Prism Medico And Pharmacy Limited
MCA filings and documents for Prism Medico And Pharmacy Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Prism Medico And Pharmacy Limited
Frequently Asked Questions about Prism Medico And Pharmacy Limited
Prism Medico And Pharmacy Limited is an active public limited company in the chemicals and materials sector based in Kala Amb, Himachal Pradesh, India. It was incorporated on 22 March 2002 (24+ years old) and is registered under CIN L24100HP2002PLC009299. Listed on BSE: 512217.
Prism Medico And Pharmacy Limited reported revenue of ₹2.44 Cr for FY 2026 (up 286.68% YoY) based on standalone BSE filings.
The current directors of Prism Medico And Pharmacy Limited are:
- Davender Singh - Director
- Pardeep Kumar - Director
- Dinesh Kumar - Director
- Sakshi Laller - Whole-Time Director
The primary industry of Prism Medico And Pharmacy Limited is chemicals and materials. The company specifically operates in industrial chemicals. The company is currently active in this sector.
Yes. Prism Medico And Pharmacy Limited is listed on BSE with code 512217.
Prism Medico And Pharmacy Limited can be reached at the registered office: Suketi Road, Kala Amb, Himachal Pradesh, India – 173030, or through the website prismmedico.com.